GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Atyr Pharma Inc (LIFE) [hlAlert]

Rating:
Buy LIFE
down 65.01 %

Invitrogen Corporation (IVGN) rated Buy

Posted on: Thursday,  Aug 2, 2007  1:25 PM ET by Am Tech/JSA Research

Am Tech/JSA Research rated Buy Atyr Pharma Inc (NASDAQ: LIFE) on 08/02/2007, when the stock price was $39.24.
Since then, Atyr Pharma Inc has lost 65.01% as of 12/16/2015's recent price of $13.73.
If you would have followed this Am Tech/JSA Research's recommendation on LIFE, you would have lost 65.01% of your investment in 3058 days.

Invitrogen Corporation provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology placing Invitrogen's products in nearly every major laboratory in the world.

American Technology Research is an employee-owned firm that provides independent, timely and focused research on information technology and defense companies for institutional investors. The firm's research analysts have strong technical backgrounds, as well as experience on both the buy- and sell-side. Their unbiased fundamental research is leveraged by a first class sales and trading capability staffed by veterans who know technology as well as execution.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/2/2007 1:25 PM Buy
None
39.24 42.50
as of 8/27/2015
1 Week down  -24.62 %
1 Month down  -36.37 %
3 Months down  -32.16 %
1 YTD down  -81.58 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy